mhurhangee/ep-ind-claims huggingface dataset:
A method of toxicological evaluation of a candidate substance on at least one tissue or organ, characterized in that it comprises the steps of: (a) obtaining a bioartificial tissue or organ by simulation or modelling of the metabolic activity of said tissue or organ by several bioreactors assembled in series or in parallel and in which are successively cultured various cell families which together simulate the tissue or organ; (b) exposure of said bioartificial tissue or organ to said substance; (c) observation of the metabolic response of the bioartificial tissue or organ and acquisition of an associated multidimensional data set without making a hypothesis concerning the metabolic response of the tissue; (d) identification by means of a method of multivariate statistical analysis of the components of the multidimensional data set which are quantitatively correlated with predetermined variables; (e) generation of a predictive model on the basis of the components of the data set actually selected; (f) testing of the predictive nature of said model by at least one statistical method of estimating reliability; (g) identification of the metabolic response of the bioartificial tissue or organ in the form of biomarkers associated with the components of the data set selected for the model. (a) obtaining a bioartificial tissue or organ by simulation or modelling of the metabolic activity of said tissue or organ by several bioreactors assembled in series or in parallel and in which are successively cultured various cell families which together simulate the tissue or organ; (b) exposure of said bioartificial tissue or organ to said substance; (c) observation of the metabolic response of the bioartificial tissue or organ and acquisition of an associated multidimensional data set without making a hypothesis concerning the metabolic response of the tissue; (d) identification by means of a method of multivariate statistical analysis of the components of the multidimensional data set which are quantitatively correlated with predetermined variables; (e) generation of a predictive model on the basis of the components of the data set actually selected; (f) testing of the predictive nature of said model by at least one statistical method of estimating reliability; (g) identification of the metabolic response of the bioartificial tissue or organ in the form of biomarkers associated with the components of the data set selected for the model.
Method for operating a drive train having an electromotive drive, wherein a rotational speed and a drive torque of the drive can be converted via a toothed gear stage for an output, and the drive is controlled by a control signal, wherein a periodic torque change signal is superimposed on the control signal, which periodic torque change signal alternately reduces and increases the drive torque and in the process is in phase with a change in tooth stiffness of the toothed gear stage, wherein a signal strength of the torque change signal with a decreasing tooth stiffness is lower than with an increasing tooth stiffness, characterized in that the periodic torque change signal simulates the tooth stiffness and is stored in a table or is described by a mathematical function with which the tooth stiffness is approximated. a rotational speed and a drive torque of the drive can be converted via a toothed gear stage for an output, and the drive is controlled by a control signal, wherein a periodic torque change signal is superimposed on the control signal, which periodic torque change signal alternately reduces and increases the drive torque and in the process is in phase with a change in tooth stiffness of the toothed gear stage, wherein a signal strength of the torque change signal with a decreasing tooth stiffness is lower than with an increasing tooth stiffness, characterized in that the periodic torque change signal simulates the tooth stiffness and is stored in a table or is described by a mathematical function with which the tooth stiffness is approximated.
An armrest assembly for a seat, the armrest assembly comprising: a base; an armrest comprising an underside and an upper surface configured to support a user's arm; and a first shaft slidably coupled to the base and pivotably coupled to the underside of the armrest a second shaft slidably coupled to the base and pivotably coupled to the underside of the armrest; a locking mechanism comprising a first clamp ring disposed around the first shaft and a second clamp ring disposed around the second shaft, wherein each of the first clamp ring and the second clamp ring comprises two portions coupled together via a spring element, the locking mechanism being configured to reversibly lock the first shaft and the second shaft in a locked configuration and reversibly release the first shaft and the second shaft in a released configuration, wherein in the locked configuration the first shaft and the second shaft are prevented from sliding relative to the base and wherein in the released configuration the first shaft and the second shaft are allowed to slide relative to the base; and a graspable handle configured to actuate the locking mechanism between the locked configuration and the released configuration, wherein the graspable handle is configured to actuate both the first clamp ring and the second clamp ring. a base; an armrest comprising an underside and an upper surface configured to support a user's arm; and a first shaft slidably coupled to the base and pivotably coupled to the underside of the armrest a second shaft slidably coupled to the base and pivotably coupled to the underside of the armrest; a locking mechanism comprising a first clamp ring disposed around the first shaft and a second clamp ring disposed around the second shaft, wherein each of the first clamp ring and the second clamp ring comprises two portions coupled together via a spring element, the locking mechanism being configured to reversibly lock the first shaft and the second shaft in a locked configuration and reversibly release the first shaft and the second shaft in a released configuration, wherein in the locked configuration the first shaft and the second shaft are prevented from sliding relative to the base and wherein in the released configuration the first shaft and the second shaft are allowed to slide relative to the base; and a graspable handle configured to actuate the locking mechanism between the locked configuration and the released configuration, wherein the graspable handle is configured to actuate both the first clamp ring and the second clamp ring.
An outdoor television with a waterproof structure, comprising: a display module, a control component of the display module and a cover body covering outside the display module and the control component, the control component being located in an upper position of the outdoor television, and the top of the cover body covering the top of the display module, characterized in that the cover body comprises a first cover plate, a second cover plate and an integrated frame; the second cover plate covers on a rear portion of the display module; the first cover plate covers on upper portions of the display module and the second cover plate, the top of the first cover plate covers the top of the display module and is in airtight connection with a front edge of the display module, and butt jointed portions of the first cover plate and the second cover plate are in airtight connection; and the integrated frame is nested at the bottom and the side portion of the display module, and the integrated frame is in airtight connection with the corresponding first cover plate and the edge of the display module. the cover body comprises a first cover plate, a second cover plate and an integrated frame; the second cover plate covers on a rear portion of the display module; the first cover plate covers on upper portions of the display module and the second cover plate, the top of the first cover plate covers the top of the display module and is in airtight connection with a front edge of the display module, and butt jointed portions of the first cover plate and the second cover plate are in airtight connection; and the integrated frame is nested at the bottom and the side portion of the display module, and the integrated frame is in airtight connection with the corresponding first cover plate and the edge of the display module.
An exhaust pipe, comprising: an inner tube that introduces an exhaust gas from an engine; and an outer tube that externally fits on the inner tube, wherein projecting portions that project inwardly in the radial direction and continue in the longitudinal direction are formed on the inner peripheral surface of the outer tube; and a plurality of air chambers partitioned by the projecting portions are formed between the outer peripheral surface of the inner tube and the inner peripheral surface of the outer tube; characterized in that five or more projecting portions are provided and in that an intermediate member is provided between the outer peripheral surface of the inner tube and the projecting portions. an inner tube that introduces an exhaust gas from an engine; and an outer tube that externally fits on the inner tube, wherein projecting portions that project inwardly in the radial direction and continue in the longitudinal direction are formed on the inner peripheral surface of the outer tube; and a plurality of air chambers partitioned by the projecting portions are formed between the outer peripheral surface of the inner tube and the inner peripheral surface of the outer tube; characterized in that five or more projecting portions are provided and in that an intermediate member is provided between the outer peripheral surface of the inner tube and the projecting portions.
A thermostable cellobiohydrolase, having a cellobiohydrolase catalytic domain comprising: a polypeptide comprising an amino acid sequence represented by SEQ ID NO: 1 or 2,, or a polypeptide comprising an amino acid sequence having 75% or greater sequence identity with the amino acid sequence represented by SEQ ID NO: 1 or 2, and having hydrolysis activity against a substrate of phosphoric acid swollen Avicel at least under conditions of 75°C and pH 5.5. a polypeptide comprising an amino acid sequence represented by SEQ ID NO: 1 or 2,, or a polypeptide comprising an amino acid sequence having 75% or greater sequence identity with the amino acid sequence represented by SEQ ID NO: 1 or 2, and having hydrolysis activity against a substrate of phosphoric acid swollen Avicel at least under conditions of 75°C and pH 5.5.
A Controller Area Network, CAN, transceiver (202, 1100, 1200, 1300) comprising: a receiver arrangement (302, 1101, 1201) for coupling to a CAN bus, the receiver arrangement configured to determine a differential signal from analog signalling received from the CAN bus; and a receive output (204, 1104, 1204) for coupling to a CAN controller and wherein the receiver arrangement is configured to provide a digital output signal to the receive output based on the differential signal; characterized in that the receiver arrangement is configured to operate in at least a first mode in which: the receiver arrangement is configured to: provide the digital output signal comprising logic 0 when the differential signal is greater than a first receiver threshold; and provide the digital output signal comprising logic 1 when the differential signal is less than said first receiver threshold (805, 806) unless said differential signal satisfies a condition, whereupon the receiver arrangement is configured to provide the digital output signal comprising logic 0, wherein the condition at least comprises the differential signal being below an activity-voltage threshold, wherein the activity-voltage threshold is below the first receiver threshold (805, 806). a receiver arrangement (302, 1101, 1201) for coupling to a CAN bus, the receiver arrangement configured to determine a differential signal from analog signalling received from the CAN bus; and a receive output (204, 1104, 1204) for coupling to a CAN controller and wherein the receiver arrangement is configured to provide a digital output signal to the receive output based on the differential signal; characterized in that the receiver arrangement is configured to operate in at least a first mode in which: the receiver arrangement is configured to: provide the digital output signal comprising logic 0 when the differential signal is greater than a first receiver threshold; and provide the digital output signal comprising logic 1 when the differential signal is less than said first receiver threshold (805, 806) unless said differential signal satisfies a condition, whereupon the receiver arrangement is configured to provide the digital output signal comprising logic 0, wherein the condition at least comprises the differential signal being below an activity-voltage threshold, wherein the activity-voltage threshold is below the first receiver threshold (805, 806). provide the digital output signal comprising logic 0 when the differential signal is greater than a first receiver threshold; and provide the digital output signal comprising logic 1 when the differential signal is less than said first receiver threshold (805, 806) unless said differential signal satisfies a condition, whereupon the receiver arrangement is configured to provide the digital output signal comprising logic 0, wherein the condition at least comprises the differential signal being below an activity-voltage threshold, wherein the activity-voltage threshold is below the first receiver threshold (805, 806).
A method of operating a point of care device, comprising: i) receiving, from a remote system in data communication with a plurality of point of care devices and configured to model a disease within a population, a protocol for operating the point of care device, the protocol based on the model and for an optimal treatment regimen, predicted by the remote system, for an individual of the population, and comprising instructions for a controller of the point of care device to perform an assay of a sample from a bodily fluid; ii) controlling the point of care device in accordance with the protocol; iii) receiving, from the remote system, and after updating the model with data indicative of the disease within the population, a different protocol based on the model and for a predicted optimal treatment regimen for the individual of the population; and iv) controlling the point of care device in accordance with the different protocol. i) receiving, from a remote system in data communication with a plurality of point of care devices and configured to model a disease within a population, a protocol for operating the point of care device, the protocol based on the model and for an optimal treatment regimen, predicted by the remote system, for an individual of the population, and comprising instructions for a controller of the point of care device to perform an assay of a sample from a bodily fluid; ii) controlling the point of care device in accordance with the protocol; iii) receiving, from the remote system, and after updating the model with data indicative of the disease within the population, a different protocol based on the model and for a predicted optimal treatment regimen for the individual of the population; and iv) controlling the point of care device in accordance with the different protocol.
A tensioner for an endless drive member, comprising: a pulley; a main piston chamber, a reservoir, and first and second fluid passageways connecting the main piston chamber and reservoir; a main piston that is movable in the main piston chamber; a check valve positioned to prevent fluid flow in one fluid flow direction between the main piston chamber and the reservoir through the second fluid passageway and to permit fluid flow in an opposing fluid flow direction between the reservoir and the main piston chamber through the second fluid passageway; a control valve that is positioned in the first fluid passageway and which is movable between a first position to provide a first flow resistance through the control valve, and a second position to provide a second flow resistance through the control valve, wherein the first flow resistance is lower than the second flow resistance; and characterized by a movable reservoir member in the reservoir that is movable based on the amount of fluid in the reservoir in such a way as to change the volume of the reservoir, wherein the reservoir, the main piston chamber and the first and second fluid passageways together are included in a fluid circuit that is substantially free of any compressible fluids, wherein the first flow resistance is non-infinite and wherein the second position for the control valve is a closed position so as to prevent flow between the reservoir and the main piston chamber through the first fluid passageway. a pulley; a main piston chamber, a reservoir, and first and second fluid passageways connecting the main piston chamber and reservoir; a main piston that is movable in the main piston chamber; a check valve positioned to prevent fluid flow in one fluid flow direction between the main piston chamber and the reservoir through the second fluid passageway and to permit fluid flow in an opposing fluid flow direction between the reservoir and the main piston chamber through the second fluid passageway; a control valve that is positioned in the first fluid passageway and which is movable between a first position to provide a first flow resistance through the control valve, and a second position to provide a second flow resistance through the control valve, wherein the first flow resistance is lower than the second flow resistance; and characterized by a movable reservoir member in the reservoir that is movable based on the amount of fluid in the reservoir in such a way as to change the volume of the reservoir, wherein the reservoir, the main piston chamber and the first and second fluid passageways together are included in a fluid circuit that is substantially free of any compressible fluids, wherein the first flow resistance is non-infinite and wherein the second position for the control valve is a closed position so as to prevent flow between the reservoir and the main piston chamber through the first fluid passageway.
A communication control device comprising: a radio communication unit configured to perform radio communication with a terminal apparatus of a primary system using a frequency band of the primary system; and a selecting unit configured to select an uplink subframe in which the frequency band is usable by a secondary system secondarily using the frequency band, the subframe being a unit of time in radio communication; wherein the radio communication unit is configured to transmit identification information of the selected subframe; and wherein time division duplexing is employed in the primary system; characterized in that a last symbol at the end of the selected subframe is set to be a guard region which is unusable by the secondary system. a radio communication unit configured to perform radio communication with a terminal apparatus of a primary system using a frequency band of the primary system; and a selecting unit configured to select an uplink subframe in which the frequency band is usable by a secondary system secondarily using the frequency band, the subframe being a unit of time in radio communication; wherein the radio communication unit is configured to transmit identification information of the selected subframe; and
Production facility for lithium-ion cells, having a plurality of production stations (20 to 22) for carrying out different process steps on the lithium-ion cells, wherein the production stations (20 to 22) are connected to one another by means of a conveying device in order for the lithium-ion cells to be transported between the production stations (20 to 22), characterized in that the production stations (20 to 22) are arranged in the region of a storage system having accommodating locations for the production stations (20 to 22), and in that, in order for lithium-ion cells to be transported directly between any two desired production stations (20 to 22), the conveying device is designed in the form of a portal conveyor having a running rail and a liftable and lowerable conveying mechanism.
A profile element for mounting a printed circuit board, wherein said profile element comprises a slotted profile (13, 15) comprising at least one profile half (13, 15), said slotted profile (13, 15) comprising two plane-parallel side walls (13', 15') at the inner end thereof forming a mounting slot adapted to surround an edge of a printed circuit board mounted in the mounting slot, wherein said at least one side wall (13', 15') comprises a fixing element (10, 11) in the form of a fixing slot (10, 11) for a PCB securing means, said fixing slot (10, 11) having an extension parallel to said mounting slot, characterized in that said PCB securing means is removably disposed, so as to effect a mounting and fixing of said printed circuit board in the mounting slot when mounted in the fixing slot (10, 11), and to effect a removal of said printed circuit board from the mounting slot when removed from the fixing slot (10, 11), the PCB securing means thus also constituting means for mounting and removal of said printed circuit board in said mounting slot.
A pharmaceutical composition for treating an ocular condition, comprising A) a biodegradable polymer matrix; and B) at least one therapeutic agent for treating said ocular condition which is homogenously dispersed within the polymer matrix; wherein the biodegradable polymer matrix contains a mixture of polymers comprising i) from about 15% to about 35% of an ester end-capped biodegradable poly(D,L-lactide) homopolymer having an inherent viscosity of 0.25 to 0.35 dL/g measured at 0.1% w/v in CHCl 3 at 25°C with an Ubbelohde size 0c glass capillary viscometer; and ii) from about 65% to about 85% of an ester end-capped biodegradable poly(D,L-lactide) homopolymer having an inherent viscosity of 1.8 to 2.2 dL/g measured at 0.1% w/v in CHCl 3 at 25°C with an Ubbelohde size 0c glass capillary viscometer. A) a biodegradable polymer matrix; and B) at least one therapeutic agent for treating said ocular condition which is homogenously dispersed within the polymer matrix; i) from about 15% to about 35% of an ester end-capped biodegradable poly(D,L-lactide) homopolymer having an inherent viscosity of 0.25 to 0.35 dL/g measured at 0.1% w/v in CHCl 3 at 25°C with an Ubbelohde size 0c glass capillary viscometer; and ii) from about 65% to about 85% of an ester end-capped biodegradable poly(D,L-lactide) homopolymer having an inherent viscosity of 1.8 to 2.2 dL/g measured at 0.1% w/v in CHCl 3 at 25°C with an Ubbelohde size 0c glass capillary viscometer.
An aqueous polymer dispersion for vibration damping comprising a film-forming polymer in the form of dispersed particles comprising a polymer phase P1 and different polymer phases P2 and P3; the polymer dispersion obtained by free radical emulsion polymerization comprising the following steps: (a) polymerization of a first monomer charge M1 to give a polymer phase P1 followed by (b) polymerization of a second monomer charge M2 in the presence of P1 to give a polymer phase P2, (c) polymerization of a third monomer charge M3 in the presence of P1 and P2 to give a polymer phase P3, wherein the difference in glass transition temperatures between P1 and P2 is at least 20°C.; the difference in glass transition temperatures between P2 and P3 is at least 5°C. and a chain transfer agent is used in the polymerization of the monomer charges M1, M2 and M3. (a) polymerization of a first monomer charge M1 to give a polymer phase P1 followed by (b) polymerization of a second monomer charge M2 in the presence of P1 to give a polymer phase P2, (c) polymerization of a third monomer charge M3 in the presence of P1 and P2 to give a polymer phase P3,